Global Encephalitis Vaccine market is expected to grow from US$ 1483 million in 2025 to US$ 2082 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

Global Encephalitis Vaccine Market Size and Outlook 2025-31

The global Encephalitis Vaccine market size is predicted to grow from US$ 1483 million in 2025 to US$ 2082 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquitos classes. People and many animals may be infection source after infection Encephalitis virus. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Encephalitis Vaccine Industry Forecast looks at past sales and reviews total world Encephalitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Encephalitis Vaccine sales for 2025 through 2031. With Encephalitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encephalitis Vaccine industry. This Insight Report provides a comprehensive analysis of the global Encephalitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encephalitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Encephalitis Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encephalitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encephalitis Vaccine. This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Inactivated Vaccine &nbsp;&nbsp;&nbsp; Live Attenuated Vaccine Segmentation by Application: &nbsp;&nbsp;&nbsp; Child &nbsp;&nbsp;&nbsp; Adult This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Valneva &nbsp;&nbsp;&nbsp; Sanofi Pasteur &nbsp;&nbsp;&nbsp; Biken &nbsp;&nbsp;&nbsp; Wuhan Institute of Biological Products &nbsp;&nbsp;&nbsp; Lanzhou Institute of Biological Products &nbsp;&nbsp;&nbsp; Chengdu Institute of Biological Products &nbsp;&nbsp;&nbsp; Tiantan Biological Products &nbsp;&nbsp;&nbsp; Liaoning Chengda &nbsp;&nbsp;&nbsp; Zhejiang Tianyuan Bio-Pharmaceutical &nbsp;&nbsp;&nbsp; Yisheng Bio &nbsp;&nbsp;&nbsp; Changchun Institute of Biological Products Key Questions Addressed in this Report What is the 10-year outlook for the global Encephalitis Vaccine market? What factors are driving Encephalitis Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Encephalitis Vaccine market opportunities vary by end market size? How does Encephalitis Vaccine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Encephalitis Vaccine Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Encephalitis Vaccine by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Encephalitis Vaccine by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Encephalitis Vaccine Segment by Type &nbsp;2.2.1 Inactivated Vaccine &nbsp;2.2.2 Live Attenuated Vaccine &nbsp;2.3 Encephalitis Vaccine Sales by Type &nbsp;2.3.1 Global Encephalitis Vaccine Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Encephalitis Vaccine Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Encephalitis Vaccine Sale Price by Type (2020-2025) &nbsp;2.4 Encephalitis Vaccine Segment by Application &nbsp;2.4.1 Child &nbsp;2.4.2 Adult &nbsp;2.5 Encephalitis Vaccine Sales by Application &nbsp;2.5.1 Global Encephalitis Vaccine Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Encephalitis Vaccine Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Encephalitis Vaccine Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Encephalitis Vaccine Breakdown Data by Company &nbsp;3.1.1 Global Encephalitis Vaccine Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Encephalitis Vaccine Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Encephalitis Vaccine Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Encephalitis Vaccine Revenue by Company (2020-2025) &nbsp;3.2.2 Global Encephalitis Vaccine Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Encephalitis Vaccine Sale Price by Company &nbsp;3.4 Key Manufacturers Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Encephalitis Vaccine Product Location Distribution &nbsp;3.4.2 Players Encephalitis Vaccine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Encephalitis Vaccine by Geographic Region &nbsp;4.1 World Historic Encephalitis Vaccine Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Encephalitis Vaccine Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Encephalitis Vaccine Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Encephalitis Vaccine Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Encephalitis Vaccine Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Encephalitis Vaccine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Encephalitis Vaccine Sales Growth &nbsp;4.4 APAC Encephalitis Vaccine Sales Growth &nbsp;4.5 Europe Encephalitis Vaccine Sales Growth &nbsp;4.6 Middle East & Africa Encephalitis Vaccine Sales Growth 5 Americas &nbsp;5.1 Americas Encephalitis Vaccine Sales by Country &nbsp;5.1.1 Americas Encephalitis Vaccine Sales by Country (2020-2025) &nbsp;5.1.2 Americas Encephalitis Vaccine Revenue by Country (2020-2025) &nbsp;5.2 Americas Encephalitis Vaccine Sales by Type (2020-2025) &nbsp;5.3 Americas Encephalitis Vaccine Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Encephalitis Vaccine Sales by Region &nbsp;6.1.1 APAC Encephalitis Vaccine Sales by Region (2020-2025) &nbsp;6.1.2 APAC Encephalitis Vaccine Revenue by Region (2020-2025) &nbsp;6.2 APAC Encephalitis Vaccine Sales by Type (2020-2025) &nbsp;6.3 APAC Encephalitis Vaccine Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Encephalitis Vaccine by Country &nbsp;7.1.1 Europe Encephalitis Vaccine Sales by Country (2020-2025) &nbsp;7.1.2 Europe Encephalitis Vaccine Revenue by Country (2020-2025) &nbsp;7.2 Europe Encephalitis Vaccine Sales by Type (2020-2025) &nbsp;7.3 Europe Encephalitis Vaccine Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Encephalitis Vaccine by Country &nbsp;8.1.1 Middle East & Africa Encephalitis Vaccine Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Encephalitis Vaccine Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Encephalitis Vaccine Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Encephalitis Vaccine Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccine &nbsp;10.3 Manufacturing Process Analysis of Encephalitis Vaccine &nbsp;10.4 Industry Chain Structure of Encephalitis Vaccine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Encephalitis Vaccine Distributors &nbsp;11.3 Encephalitis Vaccine Customer 12 World Forecast Review for Encephalitis Vaccine by Geographic Region &nbsp;12.1 Global Encephalitis Vaccine Market Size Forecast by Region &nbsp;12.1.1 Global Encephalitis Vaccine Forecast by Region (2026-2031) &nbsp;12.1.2 Global Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Encephalitis Vaccine Forecast by Type (2026-2031) &nbsp;12.7 Global Encephalitis Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Valneva &nbsp;13.1.1 Valneva Company Information &nbsp;13.1.2 Valneva Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.1.3 Valneva Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Valneva Main Business Overview &nbsp;13.1.5 Valneva Latest Developments &nbsp;13.2 Sanofi Pasteur &nbsp;13.2.1 Sanofi Pasteur Company Information &nbsp;13.2.2 Sanofi Pasteur Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.2.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Sanofi Pasteur Main Business Overview &nbsp;13.2.5 Sanofi Pasteur Latest Developments &nbsp;13.3 Biken &nbsp;13.3.1 Biken Company Information &nbsp;13.3.2 Biken Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.3.3 Biken Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Biken Main Business Overview &nbsp;13.3.5 Biken Latest Developments &nbsp;13.4 Wuhan Institute of Biological Products &nbsp;13.4.1 Wuhan Institute of Biological Products Company Information &nbsp;13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Wuhan Institute of Biological Products Main Business Overview &nbsp;13.4.5 Wuhan Institute of Biological Products Latest Developments &nbsp;13.5 Lanzhou Institute of Biological Products &nbsp;13.5.1 Lanzhou Institute of Biological Products Company Information &nbsp;13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Lanzhou Institute of Biological Products Main Business Overview &nbsp;13.5.5 Lanzhou Institute of Biological Products Latest Developments &nbsp;13.6 Chengdu Institute of Biological Products &nbsp;13.6.1 Chengdu Institute of Biological Products Company Information &nbsp;13.6.2 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Chengdu Institute of Biological Products Main Business Overview &nbsp;13.6.5 Chengdu Institute of Biological Products Latest Developments &nbsp;13.7 Tiantan Biological Products &nbsp;13.7.1 Tiantan Biological Products Company Information &nbsp;13.7.2 Tiantan Biological Products Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.7.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Tiantan Biological Products Main Business Overview &nbsp;13.7.5 Tiantan Biological Products Latest Developments &nbsp;13.8 Liaoning Chengda &nbsp;13.8.1 Liaoning Chengda Company Information &nbsp;13.8.2 Liaoning Chengda Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.8.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Liaoning Chengda Main Business Overview &nbsp;13.8.5 Liaoning Chengda Latest Developments &nbsp;13.9 Zhejiang Tianyuan Bio-Pharmaceutical &nbsp;13.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information &nbsp;13.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview &nbsp;13.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments &nbsp;13.10 Yisheng Bio &nbsp;13.10.1 Yisheng Bio Company Information &nbsp;13.10.2 Yisheng Bio Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.10.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Yisheng Bio Main Business Overview &nbsp;13.10.5 Yisheng Bio Latest Developments &nbsp;13.11 Changchun Institute of Biological Products &nbsp;13.11.1 Changchun Institute of Biological Products Company Information &nbsp;13.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications &nbsp;13.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Changchun Institute of Biological Products Main Business Overview &nbsp;13.11.5 Changchun Institute of Biological Products Latest Developments 14 Research Findings and Conclusion

Report	Global Encephalitis Vaccine Market Growth 2025-2031
Selected License	Multi ID: LPI24746

Buyer Information

Order Summary